| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |